MedTrace Logo

Tetralogy of Fallot for Life

NCT02968264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1108

Last updated 2022-12-21

No results posted yet for this study

Summary

The aim is to conduct a prospective multi-centre international inception cohort study with an enrollment goal of 3,000 TOF patients and 2 year follow-up post-repair. The proposed sample size and methodology will result in statistically powerful results to allow for evidence-based change to current TOF surgical practices.

Conditions

  • Tetralogy of Fallot
  • Congenital Heart Disease
  • Congenital Heart Defect

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Glen Van Arsdell, MD · University of California, Los Angeles

  • Richard Whitlock, MD, PhD · Population Health Research Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-08
Primary Completion
2022-03-15
Completion
2022-07-01

Countries

  • United States
  • Australia
  • Canada
  • China
  • India
  • Indonesia
  • Japan
  • Nepal
  • Russia
  • Saudi Arabia
  • South Korea
  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02968264 on ClinicalTrials.gov